Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Quest Diagnostics (DGX) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY26 Guidance

April 21, 2026 6:49 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $2.50, $0.13 better than the analyst estimate of $2.37. Revenue for the quarter came in at $2.9 billion versus the consensus estimate of $2.83 billion.

GUIDANCE:

Quest Diagnostics sees FY2026 EPS of $10.63-$10.83, versus the consensus of $10.63.... More